Secondary Progressive Multiple Sclerosis
Also known as: Secondary-progressive Multiple Sclerosis (SPMS) / Secondary Multiple Sclerosis, Progressive / Multiple Sclerosis, Secondary Progressive / Secondary-progressive Multiple Sclerosis / Secondary Progressive Multiple Sclerosis (SPMS) / Secondary Progressive MS (SPMS) / Secondary Progressive MS / Secondary progressive multiple sclerosis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00087 | Alemtuzumab | A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. |
DB00068 | Interferon beta-1b | A form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms. |
DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
DB00108 | Natalizumab | A monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis. |
DB09122 | Peginterferon beta-1a | An interferon beta used to treat relapsing forms of multiple sclerosis. |